Thema
Letter
Comment
10.340
COVID-19
4.648
COVID-19 Vaccines
2.761
Research Support, Non-U.S. Gov't
2.581
Case Reports
1.682
SARS-CoV-2
1.611
Antibodies, Viral
1.026
Research Support, N.I.H., Extramural
574
Antiviral Agents
527
BNT162 Vaccine
466
N38TVC63NU
391
RNA, Viral
387
Hydroxychloroquine
372
4QWG6N8QKH
369
Spike Glycoprotein, Coronavirus
367
Antibodies, Neutralizing
352
RNA, Messenger
338
Vaccines
313
spike protein, SARS-CoV-2
292
Antibodies, Monoclonal, Humanized
289
Angiotensin-Converting Enzyme 2
276
EC 3.4.17.23
276
Biomarkers
271
Coronavirus
251
Anticoagulants
245
Covid-19
245
Observational Study
241
Immunoglobulin G
236
coronavirus
225
Multicenter Study
221
Review
218
ACE2 protein, human
198
Pandemic
198
EC 3.4.15.1
193
Peptidyl-Dipeptidase A
192
ChAdOx1 nCoV-19
176
B5S3K2V0G8
173
Meta-Analysis
173
tocilizumab
165
Anti-Bacterial Agents
163
Immunosuppressive Agents
163
I031V2H011
162
epidemiology
161
Aerosols
158
Cytokines
156
Adrenal Cortex Hormones
155
Clinical Trial Protocol
139
Comparative Study
135
2019-nCoV Vaccine mRNA-1273
133
mehr ...